Results 161 to 170 of about 998,540 (257)

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

open access: yesArthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi   +12 more
wiley   +1 more source

Are editors of scientific journals doing justice? [PDF]

open access: yesIndian J Thorac Cardiovasc Surg, 2020
Yadava OP.
europepmc   +1 more source

Dysregulation of U12‐Type Splicing in Lupus Neutrophils

open access: yesArthritis &Rheumatology, Accepted Article.
Abstract. Objective Neutrophil dysfunction is a hallmark of systemic lupus erythematosus (SLE), but its molecular basis remains unclear. This study explores transcriptional and post‐transcriptional changes in low‐density granulocytes (LDGs), a proinflammatory neutrophil subset expanded in SLE, focusing on NADPH oxidase (Nox) function and minor intron ...
Luz P. Blanco   +11 more
wiley   +1 more source

[A New Era for the Scientific Journals of the IMSS]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Moctezuma-Paz A   +2 more
europepmc   +1 more source

Detection of plagiarism among rhinology scientific journals. [PDF]

open access: yesInt Forum Allergy Rhinol
Benaim EH   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy